IP Library Granted Patent US 7,338,777
Granted Patent B2
US 7,338,777 · App. 10/868,798 · Granted Mar 4, 2008

Method for determining the biological activity of defibrotide

Assignee: Gentium SPA
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,338,777
App. No.
10/868,798
Granted
Mar 4, 2008
Kind
B2
Abstract

Method for determining the biological activity of defibrotide by a) bringing into contact defibrotide, plasmin and a substrate specific for the plasmin which, by reaction with the plasmin, provides a measurable product; and b) measuring the amount of product formed at successive times, to thereby determine the biological activity of the defibrotide.

Claims (23)

1. A method for determining the biological activity of defibrotide, which comprises the steps of:

a) bringing into contact defibrotide, plasmin and a substrate specific for the plasmin which, by reaction with the plasmin, provides a measurable product; and

b) measuring the amount of product formed at successive times, to thereby determine the biological activity of the defibrotide.

2. The method according to claim 1 , wherein the plasmin is a mammalian plasmin.

3. The method according to claim 2 , wherein the plasmin is human plasmin.

4. The method according to claim 1 , wherein the substrate specific for the plasmin is a compound of formula

A 1 -A 2 -A 3 -X

in which A 1 and A 2 are non-polar amino acids, A 3 is lysine or arginine and X is the measurable product.

5. The method according to claim 4 , wherein the measurable product X is selected from the group consisting of para-nitroaniline and 2-naphthylamine.

6. The method according to claim 4 , wherein the substrate for the plasmin is H-D-Valyl-L-Leucyl-L-Lysine-p-nitroaniline.

7. The method according to claim 4 , wherein the measurable product X is measured by spectrophotometry.

8. The method according to claim 1 , wherein the plasmin has a concentration of from 0.0064 to 0.050 I.U./ml and the substrate for the plasmin has a concentration of from 2.5 to 3.5 mM.

9. The method according to claim 8 , wherein the concentration of plasmin is 0.0125 I.U./ml and the concentration of the substrate for the plasmin is 3 mM.

10. The method according to claim 1 , wherein the reaction is carried out in a reaction medium which is an aqueous solution buffered to a pH of from 7 to 8.

11. The method according to claim 10 , wherein the reaction medium is an aqueous solution buffered to a pH of 7.4.

12. The method according to claim 1 , wherein the temperature is maintained at from 35 to 39° C.

13. The method according to claim 12 , wherein the temperature is maintained at 37° C.

14. The method according to claim 1 , wherein the concentration of the substrate for the plasmin is from 0.3 to 4 mM.

15. The method according to claim 14 , wherein the concentration of the substrate for the plasmin is from 2.5 to 3.5 mM.

16. The method according to claim 14 , wherein the concentration of the substrate for the plasmin is 3 mM.

17. A method for determining the biological activity of defibrotide according to claim 1 , which method comprises the steps of:

a) determining the rate of release of the measurable product during the course of the enzymatic reaction of both a standard sample and a test sample;

b) correlating, mathematically and/or graphically, the rate of release with the corresponding defibrotide concentration to obtain the biological activity of the test sample of defibrotide.

Assignments (2)
CHANGE OF NAME Recorded Oct 11, 2016
From: GENTIUM S.P.A.
To: GENTIUM S.R.L.
Reel/Frame 040314/0568 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2004
From: PORTA, ROBERTO; CATTANEO, FRANCO; FERRO, LAURA
To: GENTIUM SPA
Reel/Frame 016468/0168 →
Priority Claims (1)
EP 01830770 · Dec 17, 2001 · regional
Continuity (2)
Continuation In Part PCTEP021337100 · Nov 27, 2002
Related Publication 20050009131A1 · Jan 13, 2005